Approval for the product development protocol (pdp) for the keramos ceramic/ceramic total hip system.  This device is indicated for usc in patients requiring primary total hip arthroplasty for the treatment of inflammatory tissue disorders and noninflammatory degenerative joint disease, including osteoarthritis,  post-traumatic arthritis or secondary arthritis, and avascular necrosis.